National
Sigh of relief as shutdown ends
HIV service providers spared; staffers return to work
Some federal workers are troubled over accusations made by Sarah Palin and others that the U.S. Park Service is being disrespectful to veterans by denying access to monuments in Washington. (Photo by Therealbs2002; courtesy Wikimedia Commons)
UPDATE: The federal government shutdown ended Thursday and thousands of employees returned to work in D.C. and across the country. This story was posted shortly before Congress passed a bill to fund the government and avert a default:
As the federal government’s shutdown entered its third week, LGBT and AIDS advocates expressed alarm that community-based AIDS service providers in D.C. and across the nation could be forced to lay off employees and curtail services if the shutdown and its related funding reductions continued much longer.
Democratic and Republican leaders in the Senate announced a bipartisan agreement on Wednesday calling for raising the debt ceiling and ending the government shutdown. Although political observers thought there were enough votes to approve the agreement in both the Senate and the House, no one was certain whether the GOP-controlled House would pass the compromise bill initiated in the Senate.
Leonard Hirsch (Washington Blade photo by Michael Key)
Leonard Hirsch, president of the LGBT federal workers group Federal GLOBE, said that, like all federal workers, thousands of furloughed LGBT federal employees continued as of Wednesday to struggle without a paycheck.
The shutdown, which closed many but not all federal agencies, left more than 800,000 federal employees furloughed, according to the U.S. Office of Personnel Management. With the federal government being the largest employer in the D.C. metro area, the area is said to have been affected the most by the shutdown.
“Everyone that I know in the federal workforce is very frustrated that they’re not allowed to be getting work done, that things are piling up, that their clients are not being served,” said Hirsch, who has worked at the Smithsonian Institution for 24 years.
Hirsch said he and nearly all the federal workers he knows – LGBT and straight – are especially troubled over accusations by Obama administration critics, including former GOP vice presidential candidate Sarah Palin, that the U.S. Park Service is being disrespectful to veterans and other citizens by denying them access to the World War II Memorial and other monuments in Washington.
“The law is clear,” he said. “If Congress has not appropriated money you cannot work on things and do things. And so we can’t open parks. We can’t open museums and monuments because Congress has not appropriated the money.”
Added Hirsch, “I don’t know a single person at the Park Service who is happy about closing doors, and I know a lot of people at the Park Service…It’s putting the federal worker in this horrible bind to say we can’t do these things and being abused for following Congress’s direction.”
Don Blanchon (Washington Blade file photo by Michael Key)
Don Blanchon, executive director of Whitman-Walker Health, the D.C. area’s largest private agency providing medical and social services to people with HIV and the LGBT community, said Whitman-Walker has “weathered” the federal shutdown so far largely because it accumulated a substantial reserve fund over the past several years.
“By and large, the impact of the shutdown directly on our operations and patient care is minimal,” he told the Blade on Monday. “We’re open. We’re serving patients. And for the foreseeable future we don’t see this shutdown causing us a tremendous amount of difficulty right now,” he said.
But Blanchon noted that Whitman-Walker along with other D.C. community-based health groups serving people with HIV has been hit by D.C.’s inability to pay its Medicaid reimbursements. Under a federal law, D.C. is prohibited from spending its own money obtained through local tax revenue if Congress doesn’t approve the city’s annual budget.
With Congress deadlocked over the federal budget, under which the D.C. budget falls, the city has been unable to spend much of its own funds since the federal shutdown began on Oct. 1 at the start of the new fiscal year. Since D.C.’s budget is intertwined with the federal budget, D.C. has been impacted by the shutdown in a way that no other city or state has, a development that has infuriated D.C. Mayor Vincent Gray.
At an Oct. 11 town hall meeting Gray said the shutdown has forced the city to tap into its reserve funds to keep city agencies open and to continue city services through the end of this week or next, at which time he said the usable portion of the reserve fund would be depleted.
But Gray said the reserve fund wasn’t large enough to enable the city to cover $90 million in Medicaid reimbursement payments to the city’s private clinics and medical providers that take Medicaid patients during the previous week.
Blanchon said the delay in the Medicaid payments resulted in Whitman-Walker not receiving about $70,000 in reimbursements for its Medicaid patients.
While Whitman-Walker’s reserve fund will enable the LGBT health provider to “weather the storm” for the time being, as Blanchon put it, other community-based health providers don’t have such a financial cushion, officials with those groups have said. Some of them have already been forced to lay off employees and curtail services, including HIV-related services, the officials have said.
Ruby Corado (Washington Blade file photo by Michael Key)
“We’re already seeing services cut back for LGBT and Latino community clients,” said Ruby Corado, director of the LGBT community center Casa Ruby. Corado said Casa Ruby, which is funded largely by private donors, wasn’t immediately affected by the shutdown.
Ron Simmons, executive director of Us Helping Us, a D.C.-based HIV service provider that reaches out to black gay men, said his group has also managed to get buy for the past two weeks “without any noticeable impact.”
But Simmons said Us Helping Us won’t be able to operate without possible service interruptions if the federal shutdown continues indefinitely. Although his organization doesn’t have the type of reserve fund that Whitman-Walker has, Simmons said much of the group’s federal funding for the fiscal year has already been appropriated by Congress through various grants. He said the payments through those grants, including one from the U.S. Centers for Disease Control and Prevention, have continued uninterrupted during the shutdown.
Similar to other HIV service providers in D.C. and across the nation, funding from the Ryan White federal AIDS program also had been appropriated by Congress prior to the shutdown, enabling groups receiving Ryan White grants to continue to receive the funds through the rest of the fiscal year, according to Carl Schmid, deputy director of the AIDS Institute, a national HIV/AIDS advocacy organization.
Carl Schmid (Washington Blade file photo by Michael Key)
“Luckily, the grants went out in April,” said Schmid in referring to the Ryan White program, which he said provides millions of dollars to AIDS groups across the country.
But Schmid cautioned that if the federal shutdown were to continue, AIDS service providers would be adversely impacted in a number of ways.
One immediate effect, he said, was federal officials who provide support for the processing of Ryan White grant applications were furloughed as soon as the shutdown began on Oct. 1.
“The new grant applications are due Oct. 31,” he said. “So what if people have questions about putting their grant applications together in the cities and states? Right now there’s no one to turn to.”
Schmid noted that most of the federal officials that administer the Obama administration’s national AIDS strategy program as well as the White House Office on AIDS Policy were also on furlough since Oct. 1.
“One or two days are one thing,” said Schmid. “But now this is going on too long and we’re definitely going to have ramifications. Let’s hope this gets solved soon.”
Michael Cole-Schwartz, a spokesperson for the Human Rights Campaign, told the Blade that LGBT-related implications of the shutdown could, among other things, include a cutback in the enforcement of the federal hate crimes act that covers hate crimes targeting LGBT people.
Cole-Schwartz said the furloughing of Justice Department personnel could negatively impact enforcement of both the hate crimes law and Title IX of an existing civil rights statute that protects women and transgender people from gender-related discrimination.
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Long-awaited ‘Pillion’ surpasses the sexy buzz
Reasons to be optimistic about 2026
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Using movement to boost your mental health during holidays
